Koyfin Home > Directory > Health Care > Abeona Therapeutics > Cash from Financing Activities

Abeona Therapeutics Cash from Financing Activities Chart (ABEO)

Abeona Therapeutics annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Abeona Therapeutics Cash from Financing Activities for the quarter ending June 06, 2020 was $2m a -572.89% decrease of -11m year over year
  • Abeona Therapeutics Cash from Financing Activities for the last 12 months ending June 06, 2020 was $103m a 83.10% increase of 85m year over year
  • Abeona Therapeutics Annual Cash from Financing Activities for 2019 was $114m a 95.19% increase of 108m from 2018
  • Abeona Therapeutics Annual Cash from Financing Activities for 2018 was $5m a -1,587.11% decrease of -87m from 2017
  • Abeona Therapeutics Annual Cash from Financing Activities for 2017 was $92m a 53.97% increase of 50m from 2016
Other Cash Flow Metrics:
  • Abeona Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-9m a 41.08% decrease of -4m year over year
  • Abeona Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-5m a 46.02% decrease of -2m year over year
  • Abeona Therapeutics Total Revenue for the quarter ending September 09, 2018 was $2m a 87.42% increase of 1m year over year
View Chart On Koyfin

Quarterly ABEO Cash from Financing Activities Data

06/2020$2m
12/2019$97m
09/2019$4m
06/2019$13m
03/2019$0m
12/2018$0m
09/2018$3m
06/2018$1m
03/2018$2m
12/2017$87m

Annual ABEO Cash from Financing Activities Data

2019$114m
2018$5m
2017$92m
2016$43m
2015$36m
2014$13m
2013$0m
2012$2m
2011$3m
2010$13m